在T1桃体状细胞癌患者中,淋巴结转移的风险根据诊断时的年龄分层

Yujiao Li1, Chaosu Hu1

  • 1Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai 201321, China; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai 201321, China; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai 201321, China; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Shanghai, China.

概括

年轻的桃体状细胞癌 (TSCC) 患者患有淋巴结转移 (LNM) 的风险更高. 高龄与较低的LNM风险有关,除亚洲患者外,建议量身定制的治疗方法.